We look back at highlights from a quarter-century of medical action in Homa Bay.
Access to affordable liposomal amphotericin B (L-AmB) crucial to ending cryptococcal meningitis deaths by 2030
2 June 2021 - As negotiations continue on the declaration for the upcoming UN High-Level Meeting (HLM) on HIV/AIDS, Médecins Sans Frontières (MSF) urges all member states to recognise and retain the full rights and use of internationally agreed public health safeguards enshrined in the Agreement on Trade-related Intellectual Property Rights (TRIPs) for access to affordable generic antiretroviral (ARV) drugs and other medicines for HIV.
Can we do what needs to be done to stop people dying from HIV/AIDS? Maybe – but only if we pay more attention to the people who are most at risk of dying. World leaders will discuss the next steps in the fight against the disease at the UN High Level Meeting on HIV/AIDS on the 8-10th of June 2021. The political declaration they’re expected to adopt, must contain clear and tangible commitments to tackle HIV related mortality and a specific focus on early detection and treatment of the main killer diseases linked to Advanced HIV Disease (AHD or AIDS).
For the more than 114,000 people living with HIV (PLHIV) currently on treatment in Homa Bay County, impending stockouts risk forcing many to interrupt their treatment, wiping away recent gains in suppressing the deadly infection.
Five people, five reasons why we need governments to back this key waiver on patents and monopolies for COVID-19 medical tools during the pandemic.
Ntezimana Fidès, from Burundi, works for Médecins Sans Frontières/Doctors Without Borders (MSF) in Nduta refugee camp, northwestern Tanzania, where she provides support to pregnant women with HIV, who often face stigma, even from their own husbands. She outlines how her work has changed with COVID-19 and describes the joy of being able to help her community.
Following the results of a 2012 study in Ndhiwa Sub-County in Kenya, a massive, collective effort was launched by MSF with the Kenyan Ministry of Health, along similar initiatives by EGPAF and PEPFAR partners, to drive an improvement in the HIV cascade of care, in order to reduce the number of people capable of transmitting the virus, thereby aiming to reduce the incidence.